The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer

作者: Mariyam Zuberi , Imran Khan , Gauri Gandhi , P. C. Ray , Alpana Saxena

DOI: 10.1007/S13277-016-4993-2

关键词: OncologyInternal medicineLymph nodeTumor progressionCarcinogenesisBiologyReceiver operating characteristicmicroRNABiomarker (medicine)Ovarian cancerPathologyMetastasis

摘要: Epithelial ovarian cancer (EOC) is the most lethal cause of morbidity and mortality worldwide. miRNA deregulation evinces a remarkable role in tumorigenesis. miRNA-199a (miR-199a) known to be involved development progression. Although miR-199a has been studied various cell types, its correlation with clinicopathological features EOC not documented. In this study, we identified hallmarks which might perturbed due downregulation serum EOC. Seventy samples from histopathologically confirmed patients 70 controls were collected. Total RNA was isolated by Trizol method, polyadenylated reverse transcribed into cDNA. Expression level detected using qRT-PCR. Relative expression determined matched U6 snRNA as reference. Level compared distinct features. found significantly downregulated comparison normal controls. The associated tumor stage, lymph node metastasis, distal metastasis. Receiver operating characteristic (ROC) curve for diagnostic potential yielded significant area under (AUC) considerable sensitivity specificity. ROC curves prognosis AUCs histological grade, status, survival. Our findings suggest that indicator disease progression promoting aggressive marker predict survival patients.

参考文章(29)
Emanuela Minna, Paola Romeo, Loris De Cecco, Matteo Dugo, Giuliana Cassinelli, Silvana Pilotti, Debora Degl’Innocenti, Cinzia Lanzi, Patrizia Casalini, Marco A. Pierotti, Angela Greco, Maria Grazia Borrello, miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. Oncotarget. ,vol. 5, pp. 2513- 2528 ,(2014) , 10.18632/ONCOTARGET.1830
T Matsumura, K Sugimachi, H Iinuma, Y Takahashi, J Kurashige, G Sawada, M Ueda, R Uchi, H Ueo, Y Takano, Y Shinden, H Eguchi, H Yamamoto, Y Doki, M Mori, T Ochiya, K Mimori, Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer British Journal of Cancer. ,vol. 113, pp. 275- 281 ,(2015) , 10.1038/BJC.2015.201
Atsushi Yamada, Takahiro Horimatsu, Yoshinaga Okugawa, Naoshi Nishida, Hajime Honjo, Hiroshi Ida, Tadayuki Kou, Toshihiro Kusaka, Yu Sasaki, Makato Yagi, Takuma Higurashi, Norio Yukawa, Yusuke Amanuma, Osamu Kikuchi, Manabu Muto, Yoshiyuki Ueno, Atsushi Nakajima, Tsutomu Chiba, C. Richard Boland, Ajay Goel, Serum miR-21, miR-29a and miR-125b are promising biomarkers for the early detection of colorectal neoplasia Clinical Cancer Research. ,vol. 21, pp. 4234- 4242 ,(2015) , 10.1158/1078-0432.CCR-14-2793
QINYU GE, YANTING SHEN, FEI TIAN, JIAFENG LU, YUNFEI BAI, ZUHONG LU, Profiling circulating microRNAs in maternal serum and plasma Molecular Medicine Reports. ,vol. 12, pp. 3323- 3330 ,(2015) , 10.3892/MMR.2015.3879
Takahiro Ichimi, Hideki Enokida, Yasushi Okuno, Ryo Kunimoto, Takeshi Chiyomaru, Ken Kawamoto, Kazuya Kawahara, Kazuki Toki, Kazumori Kawakami, Kenryu Nishiyama, Gozoh Tsujimoto, Masayuki Nakagawa, Naohiko Seki, Identification of novel microRNA targets based on microRNA signatures in bladder cancer. International Journal of Cancer. ,vol. 125, pp. 345- 352 ,(2009) , 10.1002/IJC.24390
C E Ford, S K Lau, C Q Zhu, T Andersson, M S Tsao, W F Vogel, Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. British Journal of Cancer. ,vol. 96, pp. 808- 814 ,(2007) , 10.1038/SJ.BJC.6603614
Erica Ballabio, Tracey Mitchell, Marloes S. van Kester, Stephen Taylor, Heather M. Dunlop, Jianxiang Chi, Isabella Tosi, Maarten H. Vermeer, Daniela Tramonti, Nigel J. Saunders, Jacqueline Boultwood, James S. Wainscoat, Francesco Pezzella, Sean J. Whittaker, Cornelius P. Tensen, Christian S. R. Hatton, Charles H. Lawrie, MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potential Blood. ,vol. 116, pp. 1105- 1113 ,(2010) , 10.1182/BLOOD-2009-12-256719
Yi Qu, Xiang Huang, Zhiqing Li, Junyan Liu, Jinlin Wu, Dapeng Chen, Fengyan Zhao, Dezhi Mu, miR-199a-3p Inhibits Aurora Kinase A and Attenuates Prostate Cancer Growth: New Avenue for Prostate Cancer Treatment American Journal of Pathology. ,vol. 184, pp. 1541- 1549 ,(2014) , 10.1016/J.AJPATH.2014.01.017
William CS Cho, Exploiting the therapeutic potential of microRNAs in human cancer Expert Opinion on Therapeutic Targets. ,vol. 16, pp. 345- 350 ,(2012) , 10.1517/14728222.2012.663354
Seonhoe Kim, Ui Jin Lee, Mi Na Kim, Eun-Ju Lee, Ji Young Kim, Mi Young Lee, Sorim Choung, Young Joo Kim, Young-Chul Choi, MicroRNA miR-199a* Regulates the MET Proto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2) Journal of Biological Chemistry. ,vol. 283, pp. 18158- 18166 ,(2008) , 10.1074/JBC.M800186200